Dr. Anthony Michael Calabretta, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 128 E Milltown Rd, Suite 101, Wooster, OH 44691 Phone: 330-287-2595 Fax: 330-202-3487 |
Richard Guttman, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 721 E Milltown Rd, Wooster, OH 44691 Phone: 330-287-4500 |
Tamera Lynn Robotham, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 128 E Milltown Rd, Suite 101, Wooster, OH 44691 Phone: 330-287-2595 Fax: 330-202-3487 |
Daniel P Peabody, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 721 E Milltown Rd, Wooster, OH 44691 Phone: 330-287-4669 Fax: 330-287-4665 |
Larry A Stern, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1761 Beall Ave, Wooster, OH 44691 Phone: 330-263-8759 Fax: 330-263-8752 |
Michael Bortz, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1761 Beall Ave Ste 102, Wooster, OH 44691 Phone: 330-287-2595 Fax: 330-202-3487 |
Dr. Eric James Turney, M.D. Surgery - Trauma Surgery Medicare: Accepting Medicare Assignments Practice Location: 1761 Beall Ave Ste 1b, Wooster, OH 44691 Phone: 330-202-5710 Fax: 330-202-5711 |
Dr. James Alan Slaby, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 128 E Milltown Rd, Suite 101, Wooster, OH 44691 Phone: 330-202-3350 Fax: 330-202-3356 |
Robert D Cebul, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 128 E Milltown Rd Ste 101, Wooster, OH 44691 Phone: 330-287-2595 Fax: 330-287-2595 |
Linda M Wang, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 128 E Milltown Rd, Suite 2, Wooster, OH 44691 Phone: 330-202-3353 Fax: 330-202-3428 |
News Archive
In Europe alone, more than 25,000 people die each year from infections caused by multi-resistant bacteria. Researchers from University of Copenhagen have now developed and characterized a substance that quickly and effectively kills the virulent bacteria. The substance employs a multifunctional mechanism that reduces the risk of antibiotic resistance. The findings have recently been published in the scientific journal Chemistry & Biology.
Bristol-Myers Squibb Company and AstraZeneca today announced results from an investigational Phase 3b clinical study in which the addition of ONGLYZA (saxagliptin) 5 mg to ongoing insulin therapy (with or without metformin) maintained reductions of blood sugar levels (glycosylated hemoglobin levels, or HbA1c) in adult patients with type 2 diabetes compared to the addition of placebo (with or without metformin) from 24 to 52 weeks.
Cardiovascular conditions leading to heart attacks and strokes are treated quite separately from common cancers of the prostate, breast or lung, but now turn out to involve some of the same critical mechanisms at the molecular level.
A pioneering piece of technology will allow users to experience the world through the eyes of a person with Young-Onset Parkinson's disease- which could revolutionise the way carers and medical staff treat people with the degenerative condition.
› Verified 9 days ago